Approach to Mycosis Fungoides in children: Consensus-based recommendations.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zvulunov Alex, Neale Holly, Stern Jonah, Santaguida Pasqualina, Stein Amy Buros, Koh Mark, Eichenfield Lawrence F, Guitart Joan, Goebeler Matthias, Scarisbrick Julia, Willemze Rein, Coughlin Carrie C, George Renu, Brazzelli Valeria, Marschalkó Márta, Belousova Irena, Querfeld Christiane, Bagot Martine, Szepietowski Jacek C, Papadavid Evangelina, Quaglino Pietro, Hoeger Peter, Ortiz-Romero Pablo L, Nikolaou Vasiliki, Dummer Reinhard, Aung Phyu P, Lawley Leslie, Morel Kimberly D, Ngan Bo, Wain Mary, Gameiro Ana, Lacy-Niebla Rosa María, Pope Elena
Аннотация
OBJECTIVE: This project aims to derive consensus recommendations for pediatric MF management.
METHODS: Experts from pediatric dermatology, general dermatology, dermatopathology, and pediatric hematology-oncology (N = 83) were invited to contribute to consensus recommendations. The process involved 3 electronic Delphi rounds, concluding with a final consensus meeting using a modified Nominal Group Technique for unresolved items.
RESULTS: Consensus included more clinical severity measures than tumor-node-metastasis-blood staging: pruritus, functional or esthetic impairment (eg, palms, soles, genitalia), quality of life impact, and psychological aspects (eg, embarrassment, anxiety, depression), plus parental anxiety. Ten recommendations were made for managing early and advanced pediatric MF. Disagreement emerged in choosing therapies beyond stage I of the disease.
DISCUSSION: This multinational initiative aimed to standardize optimal pediatric MF management and successfully generated consensus recommendations. Additional work is needed for structured, prospective protocols in advanced-stage pediatric MF.
LIMITATIONS: Lack of pediatric hematologists-oncologists and patients' representatives.
CONCLUSION: Documentation of extended clinical severity and outcome measures is recommended. Addressing the need for structured protocols in advanced-stage pediatric MF and implementing systematic, prospective data collection is crucial.